• Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay)

  • Oct 7 2019
  • Length: 4 mins
  • Podcast

Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay)

Listen for free

View show details

  • Summary

  • Colin Lindsay discusses the trial results for AMG 510 – a novel inhibitor targeting the KRAS G12C mutation –  in patients with locally advanced or metastatic non-small-cell lung cancer.

    Find more on Medicine Matters oncology

    More from WCLC 2019
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay)

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available